welcome
Working for the people to improve healthcare
Dr. Simó Schwartz Jr

CIBBIM-Nanomedicine Director

Dr. Simó Schwartz Jr


Nanomedicine and Advanced Therapies as translational sciences have the ultimate goal to provide cost effective novel therapies and diagnostics. As key enable technologies these new options will cause profound changes in healthcare, making feasible more personalized, predictive, preventive, and regenerative medicine.

PRECLINICAL SERVICES

This platform offers standard in vitro experimentation procedures for the functional validation of candidate genes and biomarkers, and for the efficacy and toxicological evaluation of new drugs, biomaterials and biomarkers.
Read more

At the moment, the platform offers standardin vivo experimentation procedures for the evaluation of new therapeutic targets, nanotherapies and biomarkers in the field of oncology and rare diseases.
Read more

Latest
news

News

Tres investigadores del VHIR reciben una beca de la Asociación Española Contra el Cáncer

Tres investigadores del VHIR reciben una beca de la Asociación Española Contra el Cáncer

La Asociación Española Contra el Cáncer (AECC) ha presentado hoy, con motivo del Día Mundial de la Investigación en Cáncer, la resolución de las becas para ayudar a...

Read more
Cerium oxide nanoparticles may improve hepatocellular carcinoma prognosis

Cerium oxide nanoparticles may improve hepatocellular carcinoma prognosis

Hepatocellular carcinoma is the most common liver cancer and ranks third in the world in terms of mortality. Its appearance is related to the hepatitis B and C...

Read more
Nanomedicine & Bioengineering

Publications

Novel amphiphilic chitosan micelles as carriers for hydrophobic anticancer drugs

Andreia Almeida 1, Marco Araújo 2, Ramon Novoa-Carballal 3, Fernanda Andrade 4, Hugo Gonçalves 5, Rui L Reis 3, Marlene Lúcio 6, Simó Schwartz Jr 7, Bruno Sarmento 8...

Read more